%0 Journal Article
%T Myeloid leukemia switch as immune escape from CD19 chimeric antigen receptor (CAR) therapy
%A Perna, Fabiana
%A Sadelain, Michel
%J Translational Cancer Research
%D 2016
%B 2016
%9 
%! Myeloid leukemia switch as immune escape from CD19 chimeric antigen receptor (CAR) therapy
%K 
%X Gardner et al. recently reported on two cases of mixed lineage leukemia (MLL)+ acute myeloid leukemia (AML) occurring after CD19 chimeric antigen receptor (CAR) therapy for MLL+ B-acute lymphoblastic leukemia (ALL) (1). This report provides new insights into mechanisms of immune escape from targeted immunotherapy and strategies to prevent their occurrence with adapted immune interventions.
%U https://tcr.amegroups.org/article/view/9016
%P S221-S225
%@ 2219-6803